Leptin resistance and impaired LEPR signaling contribute to the development of hepatic insulin resistance and are associated with several conditions, such as nonalcoholic fatty liver disease (NAFLD) [48, 49]. This evidence concerns the gene LEPR and metabolic dysfunction-associated steatotic liver disease.